BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2022 Earnings Call Transcript
Operator: Good morning and welcome to the BioCryst Fourth Quarter 2022 Earnings Conference Call. Please note this event is being recorded.
Source: insidermonkey.com
Page 5 - John Bluth News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from John Bluth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In John Bluth Today - Breaking & Trending Today
BioCryst Pharmaceuticals (BCRX) Q4 2022 Earnings Call Transcript
BCRX earnings call for the period ending December 31, 2022.
Source: fool.com
BioCryst Announces Preliminary Full Year 2022 ORLADEYO®
—ORLADEYO preliminary 2022 full year net revenue of $251.6 million (+105 percent y-o-y)— —ORLADEYO net revenue expected to be no less than $320 million in...
Source: globenewswire.com
BioCryst to Present at 41st Annual J.P. Morgan Healthcare Conference
RESEARCH TRIANGLE PARK, N.C., Jan. 04, 2023 -- BioCryst Pharmaceuticals, Inc. today announced that the company will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco,... | January 4, 2023
Source: marketscreener.com
BioCryst Pharmaceuticals (BCRX) Q3 2022 Earnings Call Transcript
BCRX earnings call for the period ending September 30, 2022.
Source: fool.com